202 related articles for article (PubMed ID: 37147137)
1. Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis.
Ciano-Petersen NL; Robert M; Muñiz-Castrillo S; Wucher V; Klich A; Vogrig A; Villagrán García M; Farina A; Goncalves D; Picard G; Rogemond V; Joubert B; Oliver-Martos B; Serrano-Castro PJ; Maucort-Boulch D; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37147137
[TBL] [Abstract][Full Text] [Related]
2. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
[TBL] [Abstract][Full Text] [Related]
3. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
Gresa-Arribas N; Titulaer MJ; Torrents A; Aguilar E; McCracken L; Leypoldt F; Gleichman AJ; Balice-Gordon R; Rosenfeld MR; Lynch D; Graus F; Dalmau J
Lancet Neurol; 2014 Feb; 13(2):167-77. PubMed ID: 24360484
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
Malter MP; Elger CE; Surges R
Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.
Brenner J; Mariotto S; Bastiaansen AEM; Paunovic M; Ferrari S; Alberti D; de Bruijn MAAM; Crijnen YS; Schreurs MWJ; Neuteboom RF; Damoiseaux JGMC; de Vries JM; Titulaer MJ
Neurology; 2023 May; 100(21):e2204-e2213. PubMed ID: 37015822
[TBL] [Abstract][Full Text] [Related]
6. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
Front Immunol; 2021; 12():719432. PubMed ID: 34975832
[TBL] [Abstract][Full Text] [Related]
7. CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis.
Desestret V; Chefdeville A; Viaccoz A; Bost C; Ducray F; Picard G; Rogemond V; Chaffois MO; Blanc C; Bardel C; Treilleux I; Pascual O; Antoine JC; Delattre JY; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2015 Dec; 2(6):e166. PubMed ID: 26568967
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes.
Zandi MS; Paterson RW; Ellul MA; Jacobson L; Al-Diwani A; Jones JL; Cox AL; Lennox B; Stamelou M; Bhatia KP; Schott JM; Coles AJ; Kullmann DM; Vincent A
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):708-13. PubMed ID: 25246644
[TBL] [Abstract][Full Text] [Related]
9. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
[No Abstract] [Full Text] [Related]
11. Anti-N-methyl-D-aspartate receptor encephalitis: a common cause of encephalitis in the intensive care unit.
Chen X; Li JM; Liu F; Wang Q; Zhou D; Lai X
Neurol Sci; 2016 Dec; 37(12):1993-1998. PubMed ID: 27620725
[TBL] [Abstract][Full Text] [Related]
12. Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy.
Bastiaansen AEM; de Bruijn MAAM; Schuller SL; Martinez-Hernandez E; Brenner J; Paunovic M; Crijnen YS; Mulder MJHL; Schreurs MWJ; de Graaff E; Smitt PAE; Neuteboom RF; de Vries JM; Titulaer MJ
Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 34937737
[TBL] [Abstract][Full Text] [Related]
13. Clinical features, treatments, and outcomes of patients with anti-
Xu Q; Zhu Y; Wang Q; Han J; Mao F; Zeng S; Chen S; Zhao C; Gu M; Li Z; Luo X; Fu X; Huang Y
Front Biosci (Landmark Ed); 2021 Sep; 26(9):496-503. PubMed ID: 34590462
[No Abstract] [Full Text] [Related]
14. Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis.
Guasp M; Módena Y; Armangue T; Dalmau J; Graus F
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31900318
[TBL] [Abstract][Full Text] [Related]
15. Catatonia in adult anti-NMDAR encephalitis: an observational cohort study.
Wu H; Wu C; Zhou Y; Huang S; Zhu S
BMC Psychiatry; 2023 Feb; 23(1):94. PubMed ID: 36750806
[TBL] [Abstract][Full Text] [Related]
16. CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis.
Dürr M; Nissen G; Sühs KW; Schwenkenbecher P; Geis C; Ringelstein M; Hartung HP; Friese MA; Kaufmann M; Malter MP; Madlener M; Thaler FS; Kümpfel T; Senel M; Häusler MG; Schneider H; Bergh FT; Kellinghaus C; Zettl UK; Wandinger KP; Melzer N; Gross CC; Lange P; Dreyhaupt J; Tumani H; Leypoldt F; Lewerenz J;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34697224
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of Children With Anti-N-Methyl-d-Aspartate Receptor Encephalitis After Japanese Encephalitis.
Luo H; Ding X; Li Y; Ma J; Liu B; Zhou L; Zheng Y; Jiang Y; Li X; Jiang L
Pediatr Neurol; 2022 May; 130():46-52. PubMed ID: 35325660
[TBL] [Abstract][Full Text] [Related]
18. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
[TBL] [Abstract][Full Text] [Related]
19. The relevance of NMDA receptor antibody-specific index for diagnosis and prognosis in patients with anti-NMDA receptor encephalitis.
Hümmert MW; Jendretzky KF; Fricke K; Gingele M; Ratuszny D; Möhn N; Trebst C; Skripuletz T; Gingele S; Sühs KW
Sci Rep; 2023 Aug; 13(1):12696. PubMed ID: 37542085
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]